TOP STORIES

• REGULATORY Govt Panel Member Pushes 50%-Plus Cut for Opdivo Price
  October 17, 2016

• BUSINESS Gilead Japan Trying to Dig Up Untreated Hep C Patients as Demand Ebbs
  October 14, 2016

• BUSINESS Takeda to Tighten R&D Focus, Strengthen Collaboration with Outside Parties; Main Challenge Will Be Financial
  October 13, 2016

• BUSINESS Interview: Teva Exec Says Takeda JV Can Grow Profit despite Generic Price Declines
  October 12, 2016

• BUSINESS Teva-Takeda JV Eyes Top Spot in Off-Patent Drug Market: CEO
  October 11, 2016

• ACADEMIA Osteoporosis Experts Express “Shock” at Discontinuation of Development of Odanacatib
  October 7, 2016

• REGULATORY Chuikyo OKs Application of Huge-Seller Re-Pricing to Opdivo; Payers Loath to Use Ono Sales Outlook for Calculation
  October 6, 2016

• REGULATORY Kaketsuken Faces Another Penalty over Encephalitis Vaccine Manufacturing
  October 5, 2016

• REGULATORY MHLW, PMDA Set Up “Preparatory Offices” to Plan Future Support System for Startups
  October 5, 2016

• REGULATORY Bayer Launches Recall of Hemophilia Med Kogenate over Potency Loss
  October 4, 2016

• BUSINESS Mitsubishi Tanabe Looks to Double Late-Stage Pipelines; Faster Decisions Hold Key in Curbing Costs
  October 3, 2016

• REGULATORY MHLW Says It Will Compile “Optimal Use Guidelines” for Keytruda Too
  October 3, 2016

• BUSINESS Suzuken’s Harvoni Sales Sag 70% from Peak, Wholesaler Earnings Certain to Take Hit
  September 30, 2016

• REGULATORY Drug Costs Biggest Driver of Healthcare Spending Surge: Chuikyo JMA Rep
  September 29, 2016

• BUSINESS Tokyo Startup’s Osteoarthritis Drug Hopeful on Tap for PIb Launch by Year-End
  September 28, 2016

• REGULATORY Clinical Research Bill Set to Sail through Extra Diet with Opposition Backing
  September 27, 2016

• TRENDS Japan’s Established Drug Market Shines as Renewed Opportunity for Foreign Generic Firms
  September 26, 2016

• REGULATORY Pharma, Govt Hold 1st Kanmin Taiwa Working Group Talks; Industry Calls for Trial-Friendly Environment, Discussions on Pricing
  September 23, 2016

• BUSINESS Nichi-Iko to Set up Biosimilar Dept. in October to Push Remicade Follow-On
  September 21, 2016

• BUSINESS Eisai Looks to Achieve CAGR of 55% for Fycompa with Add’l Indications
  September 20, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• …
• Next ›
• 最終 »